News About: Pharm. Industry
KFDA approved Il Yang's ilaprazole phase III study
Il Yang announced on Sept. 28 that Ilaprozole, an anti-peptic ulcer drug, obtained the KFDA approval on its phase III study for the treatment of duodenal and stomach ulcer, conducting at 15 university hospitals for on...
Moksan to acquire Dong-bang for Ginkomin business.
Moksan Pharm. Co., an American company, took over Dong-bang pharmaceutical company through the public auction in Aug. last year, and named Mr. Jeon Jong-yeol as the CEO during the general shareholder's meeting in Sept...
Daewoong to patent pravastatin composite for prolonged efficacy.
Daewoong announced that a composite of sodium pravastatin with co-polyvidon was patent registered for the improvement of its stability and thereby prolonged efficacy characterized in which co-polividon protect pravast...
Exaggerated advertising problems with 100% glucosamine products.
A necessity of ruling a false and exaggerated public advertising on 100% of glucosamine preparations has been strongly raised by Rep. Kim Seon-mi of the Uri Party, the National Assembly Health and Welfare Committee, d...
CKD to patent an anti-sepsis drug, CKD-712 in Korea.
Chongkundang (CKD) announced on Sept. 22 that CKD-712, an antibacterial agent for the treatment of sepsis and a derivative of Tetrahydroisoquinolone compounds and its manufacturing process had completed to patent in K...
LG to complete phase II study for sustained human growth hormone.
LG Life Science announced that a sustained type of human growth hormone, LB03002, had successfully completed its phase II study in Europe for the treatment of low height children, the study of which will be presented ...
KIT actively to support new drug R&D.
The Korea Institute of Toxicology (KIT), a government financed professional preclinical research institute, has introduced a screening service from the overseas for any drug toxicity by using DNA chips, thus activatin...
Government subsidy on new drug development biased to Biotech.
The government subsidy on the new drug development inclined more to the biotech areas. The government subsidy programs have also suspended on the total 10 subjects since 2003.
The MOHW report presented to the Nati...
Sam-A to patent a composite process of Carmodix suspension tablet.
Sam-A Pharm. Co. announced on Sept. 21 that the manufacturing process and the composite of Carmodix suspension tablet, a combined penicillin antibiotic of AMX/CLA made patent registration (Pat. Reg. No. 0515311) in Ko...
Hwail Inc. to get 21 DMF certified products.
Hwail Pharmaceutical company announced on Sept. 20 that 21 bulk drugs have been DMF certified by the KFDA since its enforcement from Sept. 1 this year.
The company said that the total production and import value of...
